Zentalis Pharmaceuticals (ZNTL) Other Working Capital Changes (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Other Working Capital Changes of -$973000.0 for Q1 2026, down 46.76% year-over-year from -$1.8 million in Q1 2025, and down 239.4% quarter-over-quarter from $698000.0 in Q4 2025.
Powered by 
Analysis
Zentalis Pharmaceuticals (ZNTL) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$973000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 46.76% year-over-year to -$973000.0; the TTM figure through Mar 2026 stood at -$9.8 million (down 288.74% YoY), while the FY2025 annual figure was -$3.0 million, up 51.87% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$973000.0, down from $698000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $13.3 million in Q2 2024, with the low at -$8.3 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $698000.0 (2025), against an average of $514352.9.
- Peak annual rise in Other Working Capital Changes reached 1226.07% in 2024, while the deepest fall reached 668.36% in 2024.
- Zentalis Pharmaceuticals' Other Working Capital Changes stood at $1.9 million in 2022, then tumbled by 74.64% to $479000.0 in 2023, then slumped by 147.6% to -$228000.0 in 2024, then soared by 406.14% to $698000.0 in 2025, then sank by 239.4% to -$973000.0 in 2026.
- Business Quant data shows ZNTL's Other Working Capital Changes at -$973000.0 in Q1 2026, $698000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zentalis Pharmaceuticals | 282.81 Mn | 282.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 367,000.00 |
| Jun 30, 2026 | 367,000.00 |
| Mar 31, 2026 | -973,000.00 |
| Mar 31, 2026 | -973,000.00 |
| Dec 31, 2025 | 698,000.00 |
| Dec 31, 2025 | 698,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -2.35 Mn |
| Mar 31, 2025 | -663,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Dec 31, 2024 | -228,000.00 |
| Dec 31, 2024 | -228,000.00 |
| Sep 30, 2024 | -5.44 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |